English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Testing of rapidly growing species of mycobacteria (RGM) against antibacterial agents has been shown to have some clinical utility. This work establishes the MICs of seven antimicrobial agents following the guidelines set forth by the Clinical and Laboratory Standards Institute (CLSI) against eighteen isolates of  Mycobacterium massiliense  recovered from wound samples of patients submitted to minimally invasive surgery such as arthroscopy and laparoscopy. The isolates showed susceptibility to amikacin (MIC 90  = 4  μ g/mL) and clarithromycin (MIC 90  < 1  μ g/mL) but resistance to ciprofloxacin (MIC 90  > 16  μ g/mL), doxycycline (MIC 90  > 32  μ g/mL), sulfamethoxazole (MIC 90  > 128  μ g/mL), and tobramycin (MIC 90  = 32  μ g/mL), and intermediate profile to cefoxitin (MIC 90  = 64  μ g/mL). Therefore, we suggest that the antimicrobial susceptibilities of any clinically significant RGM isolate should be performed.

minimally invasive surgery

In Vitro Antimicrobial Susceptibility of<i>Mycobacterium massiliense</i>Recovered from Wound Samples of Patients Submitted to Arthroscopic and Laparoscopic Surgeries

In Vitro Antimicrobial Susceptibility ofMycobacterium massilienseRecovered from Wound Samples of Patients Submitted to Arthroscopic and Laparoscopic Surgeries